Global Menstrual Cramps Treatment Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 4,338.30 Million |
 Market Size (Forecast Year) |
USD 9,145.12 Million |
 CAGR |
% |
| Major Markets Players |
|
>全球痛经治疗市场，按类型（原发性痛经、继发性痛经）、治疗类型（药物、疗法、手术、其他）、诊断（超声波、腹腔镜检查、CT 扫描、磁共振成像 (MRI)、其他）、处方方式（非处方、处方）、给药途径（口服、肠外、植入物、其他）、最终用户（医院、专科诊所、家庭护理、其他）、分销渠道（医院药房、零售药房、网上药房、其他）划分 - 行业趋势和预测到 2030 年。
月经痉挛治疗市场分析及规模
月经痉挛是一种强烈的痉挛，始于下腹部，可蔓延至背部和小腿。大多数女性在青春期早期开始出现剧烈疼痛，大约在月经周期开始五年后。用医学术语来说，这被称为痛经。根据 2021 年 3 月发表的一项题为“COVID-19 大流行对女性生殖健康的影响”的研究，自大流行开始以来，46% 的女性报告月经周期发生变化，其中 30% 为新的痛经病例。因此，COVID-19 对月经痉挛治疗市场产生了相当大的影响。
Data Bridge Market Research 分析，全球痛经治疗市场在 2022 年为 43.38302 亿美元，预计到 2030 年将达到 91.4512 亿美元，预计在 2023 年至 2030 年的预测期内复合年增长率为 8.30%。由于痛经治疗的普及率很高，“原发性痛经”在全球痛经治疗市场类型细分中占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。
月经痉挛治疗市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2015-2020) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
类型（原发性痛经、继发性痛经）、治疗类型（药物、疗法、手术、其他）、诊断（超声波、腹腔镜检查、CT 扫描、磁共振成像 (MRI)、其他）、处方方式（非处方、处方）、给药途径（口服、肠胃外、植入、其他）、最终用户（医院、专科诊所、家庭护理、其他）、分销渠道（医院药房、零售药房、网上药房、其他） |
|
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Baxter (U.S.), Bayer AG (Germany), Eli Lilly and Company (U.S.), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Allergan (Ireland), AbbVie Inc. (U.S.), Abbott (U.S.), Bausch Health Companies Inc. (Canada) |
|
Market Opportunities |
|
Market Definition
Dysmenorrhea is a medical name for menstrual cramps in which a woman experiences severe cramps in her lower abdomen that can migrate to her lower legs and back. Dysmenorrhea affects the majority of women during puberty, usually within four to five years following their first menstrual cycle. During menstruation, substances called prostaglandins are released into the uterine lining. These prostaglandins generate uterine muscle contractions, which are uncomfortable and reduce blood and oxygen flow to the uterus. Menstrual cramps can often be relieved with over-the-counter pain medications. Ibuprofen and other nonsteroidal anti-inflammatory medications (NSAIDs) can help ease pain.
Global Menstrual Cramps Treatment Market Dynamics
Drivers
- High Prevalence of Dysmenorrhea
Dysmenorrhea is a widespread condition, affecting a substantial portion of individuals with menstrual cycles. The sheer prevalence of dysmenorrhea acts as a powerful driver for the market, spurring the demand for effective treatment options, including pharmaceuticals and therapies.
- Increasing Awareness and Education
The growing awareness of dysmenorrhea and its impact on daily life has resulted in increased education and advocacy efforts. Healthcare professionals and advocacy groups have played a vital role in raising awareness and ensuring that individuals are aware of the available treatment options.
- Advancements in Menstrual Cramps Treatment
Continuous research and development initiatives have led to significant advancements in menstrual cramps treatment. New pharmaceutical formulations, cutting-edge pain relief technologies, and alternative remedies have enriched the arsenal of treatment options, promising improved symptom management.
Opportunities
- Personalized Treatment Plans
Tailoring treatment plans to individual needs and preferences offers a promising opportunity for improved symptom management. Healthcare providers can collaborate with patients to develop personalized approaches that may encompass a combination of treatments.
- Digital Health and Telemedicine
The ascendancy of digital health and telemedicine platforms provides convenient access to healthcare providers and information about menstrual cramps treatment. Telehealth consultations allow individuals to discuss their symptoms and receive guidance from the comfort of their homes.
Restraints/Challenges
- Side Effects of Pharmaceuticals
While pharmaceuticals provide effective pain relief for many individuals, some may experience side effects or contraindications. Issues such as nausea, gastrointestinal discomfort, and contraindications for specific medications can limit treatment options.
-
Regulatory Compliance and Safety
The development and approval of therapies for rare diseases such as menstrual cramps treatment involve navigating regulatory hurdles. Obtaining orphan drug designation and meeting regulatory requirements can be time-consuming and costly.
This global menstrual cramps treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global menstrual cramps treatment market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In December 2021, Nua had announced the launch of Cramp Comfort, a first-of-its-kind product to help with period pain. Nua, a women's wellness company, has introduced a novel self-heating patch that may provide up to 8 hours of heat to relieve period pain. Cramp Comfort is comprised entirely of natural substances and was developed after extensive study and a thorough understanding of consumer demands. A pack of three heat patches costs INR 299
Global Menstrual Cramps Treatment Market Scope
The global menstrual cramps treatment market is segmented on the basis of type, treatment type, diagnosis, mode of prescription, route of administration, end-user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Primary Dysmenorrhea
- Secondary Dysmenorrhea
Treatment Type
- Medication
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- 复方口服避孕药
- 其他的
- 治疗
- 外科手术
- 其他的
诊断
- 超声波
- 腹腔镜检查
- CT 扫描
- 磁共振成像（MRI）
- 其他的
处方方式
- 在柜台
- 处方
给药途径
- 口服
- 肠外
- 植入物
- 其他的
最终用户
- 医院
- 专科诊所
- 家庭护理
- 其他的
分销渠道
- 医院药房
- 零售药店
- 网上药店
- 其他的
全球痛经治疗市场区域分析/见解
对全球痛经治疗市场进行了分析，并按类型、治疗类型、诊断、处方方式、给药途径、最终用户和分销渠道提供了市场规模洞察和趋势。
全球痛经治疗市场报告涵盖的国家包括美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区其他地区（APAC）、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲其他地区（MEA）、巴西、阿根廷和南美洲其他地区（南美洲）
就市场份额和市场收入而言，北美在全球痛经治疗市场占据主导地位，并且由于研发支出的增加、政府举措的增多以及各国医疗保健基础设施的改善，北美将在 2023 年至 2030 年的预测期内继续保持主导地位。
另一方面，由于政府对医疗保健领域的支出不断增加以及政府的技术进步和举措不断增加，预计在 2023 年至 2030 年的预测期内，亚太地区将在全球痛经治疗市场中呈现最高的增长率。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
全球痛经治疗市场还为您提供每个国家/地区资本设备医疗支出增长、全球痛经治疗市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗监管情景的变化及其对全球痛经治疗市场的影响的详细市场分析。数据涵盖 2015 年至 2020 年的历史时期。
竞争格局和全球痛经治疗市场份额分析
全球痛经治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球痛经治疗市场的关注有关。
全球痛经治疗市场的一些主要参与者包括：
- 辉瑞公司（美国）
- 葛兰素史克公司 (英国)
- 诺华公司（瑞士）
- Mylan NV（美国）
- Teva Pharmaceutical Industries Ltd.（以色列）
- 赛诺菲（法国）
- 阿斯利康（英国）
- 强生私人有限公司（美国）
- 默克公司（美国）
- F. Hoffmann-La Roche Ltd.（瑞士）
- 百特（美国）
- 拜耳公司（德国）
- 礼来公司 (美国)
- 太阳制药工业有限公司 (印度)
- Aurobindo Pharma（印度）
- 鲁冰花（印度）
- 艾尔建（爱尔兰）
- AbbVie Inc.（美国）
- 雅培（美国）
- Bausch Health Companies Inc.（加拿大）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
